AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2019
Dec 12, 2019
34519_dirs_2019-12-12_f0058359-c2f0-455b-96c7-07dc2baafaa1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2019-12-09
Reporting Person: Brockmann Bobbi Jo (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-12-09 | Common Stock, par value $0.10 per share | A | 1200.0000 | $3.9900 | Acquired | 2255.0000 | Direct |
| 2019-12-09 | Common Stock, par value $0.10 per share | A | 1524.0000 | $3.6500 | Acquired | 3779.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-12-09 | Incentive Stock Options (Right to buy) | $3.9900 | D | 3800.0000 | Disposed | 2020-02-08 | Common Stock (3800.0000) | Direct |
| 2019-12-11 | Incentive Stock Options (Right to buy) | $5.1750 | A | 10000.0000 | Acquired | 2029-12-11 | Common Stock (10000.0000) | Direct |
| 2019-12-09 | Incentive Stock Options (Right to buy) | $3.6500 | D | 3476.0000 | Disposed | 2020-01-04 | Common Stock (3476.0000) | Direct |
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23